A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases. Some types of immunotherapy only target certain cells of the immune system. Others affect the immune system in a general way.
The report focuses on the Immunotherapy Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Immunotherapy Drugs market.
Major Players in the Immunotherapy Drugs market are:
Janssen Global Services, LLC
AstraZeneca
Pfizer
Novartis
Eli Lilly and Company
Bristol-Myers Squibb
F. Hoffmann-La Roche AG
Amgen
Bayer AG
Merck
On the basis of types, the Immunotherapy Drugs market is primarily split into:
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Other Drugs
On the basis of applications, the market covers:
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Other Therapy Area
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Immunotherapy Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Immunotherapy Drugs Market Overview
1.1 Product Overview and Scope of Immunotherapy Drugs Market
1.2 Immunotherapy Drugs Market Segment by Type
1.2.1 Global Immunotherapy Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Immunotherapy Drugs Market Segment by Application
1.3.1 Immunotherapy Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Immunotherapy Drugs Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Immunotherapy Drugs (2017-2029)
1.5.1 Global Immunotherapy Drugs Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Immunotherapy Drugs Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Immunotherapy Drugs Industry
1.7 Impact of Carbon Neutrality on the Immunotherapy Drugs Industry
2 Immunotherapy Drugs Market Upstream and Downstream Analysis
2.1 Immunotherapy Drugs Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Immunotherapy Drugs Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Janssen Global Services, LLC
3.1.1 Janssen Global Services, LLC Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Immunotherapy Drugs Market Performance (2017-2022)
3.1.4 Business Overview
3.2 AstraZeneca
3.2.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Immunotherapy Drugs Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Pfizer
3.3.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Immunotherapy Drugs Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Novartis
3.4.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Immunotherapy Drugs Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Eli Lilly and Company
3.5.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Immunotherapy Drugs Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Bristol-Myers Squibb
3.6.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Immunotherapy Drugs Market Performance (2017-2022)
3.6.4 Business Overview
3.7 F. Hoffmann-La Roche AG
3.7.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Immunotherapy Drugs Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Amgen
3.8.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Immunotherapy Drugs Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Bayer AG
3.9.1 Bayer AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Immunotherapy Drugs Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Merck
3.10.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Immunotherapy Drugs Market Performance (2017-2022)
3.10.4 Business Overview
4 Global Immunotherapy Drugs Market Landscape by Player
4.1 Global Immunotherapy Drugs Sales and Share by Player (2017-2022)
4.2 Global Immunotherapy Drugs Revenue and Market Share by Player (2017-2022)
4.3 Global Immunotherapy Drugs Average Price by Player (2017-2022)
4.4 Global Immunotherapy Drugs Gross Margin by Player (2017-2022)
4.5 Immunotherapy Drugs Market Competitive Situation and Trends
4.5.1 Immunotherapy Drugs Market Concentration Rate
4.5.2 Immunotherapy Drugs Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Immunotherapy Drugs Sales, Revenue, Price Trend by Type
5.1 Global Immunotherapy Drugs Sales and Market Share by Type (2017-2022)
5.2 Global Immunotherapy Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Immunotherapy Drugs Price by Type (2017-2022)
5.4 Global Immunotherapy Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Immunotherapy Drugs Sales, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
5.4.2 Global Immunotherapy Drugs Sales, Revenue and Growth Rate of Adult Vaccines (2017-2022)
5.4.3 Global Immunotherapy Drugs Sales, Revenue and Growth Rate of Checkpoint Inhibitors (2017-2022)
5.4.4 Global Immunotherapy Drugs Sales, Revenue and Growth Rate of Interferons Alpha & Beta (2017-2022)
5.4.5 Global Immunotherapy Drugs Sales, Revenue and Growth Rate of Interleukins (2017-2022)
5.4.6 Global Immunotherapy Drugs Sales, Revenue and Growth Rate of Other Drugs (2017-2022)
6 Global Immunotherapy Drugs Market Analysis by Application
6.1 Global Immunotherapy Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Immunotherapy Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Immunotherapy Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Immunotherapy Drugs Consumption and Growth Rate of Cancer (2017-2022)
6.3.2 Global Immunotherapy Drugs Consumption and Growth Rate of Autoimmune & Inflammatory Diseases (2017-2022)
6.3.3 Global Immunotherapy Drugs Consumption and Growth Rate of Infectious Diseases (2017-2022)
6.3.4 Global Immunotherapy Drugs Consumption and Growth Rate of Other Therapy Area (2017-2022)
7 Global Immunotherapy Drugs Sales and Revenue Region Wise (2017-2022)
7.1 Global Immunotherapy Drugs Sales and Market Share, Region Wise (2017-2022)
7.2 Global Immunotherapy Drugs Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Immunotherapy Drugs Market Forecast (2022-2029)
8.1 Global Immunotherapy Drugs Sales, Revenue Forecast (2022-2029)
8.1.1 Global Immunotherapy Drugs Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Immunotherapy Drugs Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Immunotherapy Drugs Price and Trend Forecast (2022-2029)
8.2 Global Immunotherapy Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.2.3 China Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.2.5 India Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Immunotherapy Drugs Sales and Revenue Forecast (2022-2029)
8.3 Global Immunotherapy Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Immunotherapy Drugs Revenue and Growth Rate of Monoclonal Antibodies (2022-2029)
8.3.2 Global Immunotherapy Drugs Revenue and Growth Rate of Adult Vaccines (2022-2029)
8.3.3 Global Immunotherapy Drugs Revenue and Growth Rate of Checkpoint Inhibitors (2022-2029)
8.3.4 Global Immunotherapy Drugs Revenue and Growth Rate of Interferons Alpha & Beta (2022-2029)
8.3.5 Global Immunotherapy Drugs Revenue and Growth Rate of Interleukins (2022-2029)
8.3.6 Global Immunotherapy Drugs Revenue and Growth Rate of Other Drugs (2022-2029)
8.4 Global Immunotherapy Drugs Consumption Forecast by Application (2022-2029)
8.4.1 Global Immunotherapy Drugs Consumption Value and Growth Rate of Cancer (2022-2029)
8.4.2 Global Immunotherapy Drugs Consumption Value and Growth Rate of Autoimmune & Inflammatory Diseases (2022-2029)
8.4.3 Global Immunotherapy Drugs Consumption Value and Growth Rate of Infectious Diseases (2022-2029)
8.4.4 Global Immunotherapy Drugs Consumption Value and Growth Rate of Other Therapy Area (2022-2029)
8.5 Immunotherapy Drugs Market Forecast Under COVID-19
9 Industry Outlook
9.1 Immunotherapy Drugs Market Drivers Analysis
9.2 Immunotherapy Drugs Market Restraints and Challenges
9.3 Immunotherapy Drugs Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Immunotherapy Drugs Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Immunotherapy Drugs Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Immunotherapy Drugs Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global 5-Fluorouracil Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 76
The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030.
North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
Global Carboplatin Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
Global Neutropenia Drugs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 96
The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
Global Small Molecule Cancer Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
Global Capecitabine Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 80
Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
Global Oxaliplatin Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely.
In this report, only The finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
Global Cancer Treatment Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
Global Capecitabine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period.
The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Methotrexate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
